Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors

Olsen, GW; Church, TR; Miller, JP; Burris, JM; Hansen, KJ; Lundberg, JK; Armitage, JB; Herron, RM; Medhdizadehkashi, Z; Nobiletti, JB; O'Neill, EM; Mandel, JH; Zobel, LR

HERO ID

3748772

Reference Type

Journal Article

Year

2003

Language

English

PMID

14644663

HERO ID 3748772
In Press No
Year 2003
Title Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors
Authors Olsen, GW; Church, TR; Miller, JP; Burris, JM; Hansen, KJ; Lundberg, JK; Armitage, JB; Herron, RM; Medhdizadehkashi, Z; Nobiletti, JB; O'Neill, EM; Mandel, JH; Zobel, LR
Journal Environmental Health Perspectives
Volume 111
Issue 16
Page Numbers 1892-1901
Abstract Perfluorooctanesulfonyl fluoride-based products have included surfactants, paper and packaging treatments, and surface protectants (e.g., for carpet, upholstery, textile). Depending on the specific functional derivatization or degree of polymerization, such products may degrade or metabolize, to an undetermined degree, to perfluorooctanesulfonate (PFOS), a stable and persistent end product that has the potential to bioaccumulate. In this investigation, a total of 645 adult donor serum samples from six American Red Cross blood collection centers were analyzed for PFOS and six other fluorochemicals using HPLC-electrospray tandem mass spectrometry. PFOS concentrations ranged from the lower limit of quantitation of 4.1 ppb to 1656.0 ppb with a geometric mean of 34.9 ppb [95% confidence interval (CI), 33.3-36.5]. The geometric mean was higher among males (37.8 ppb; 95% CI, 35.5-40.3) than among females (31.3 ppb; 95% CI, 30.0-34.3). No substantial difference was observed with age. The estimate of the 95% tolerance limit of PFOS was 88.5 ppb (upper limit of 95% CI, 100.0 ppb). The measures of central tendency for the other fluorochemicals (N-ethyl perfluorooctanesulfonamidoacetate, N-methyl perfluorooctanesulfonamidoacetate, perfluorooctanesulfonamidoacetate, perfluorooctanesulfonamide, perfluorooctanoate, and perfluorohexanesulfonate) were approximately an order of magnitude lower than PFOS. Because serum PFOS concentrations correlate with cumulative human exposure, this information can be useful for risk characterization.
Doi 10.1289/ehp.6316
Pmid 14644663
Wosid WOS:000187034000035
Url <Go to ISI>://WOS:000187034000035
Is Certified Translation No
Dupe Override No
Is Public Yes
Language Text English
Keyword American Red Cross; biomonitoring; blood donors; fluorochemicals; perfluorooctanesulfonate; perfluorooctanoate; PFOA; PFOS